Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics(NBRV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-08 AccNo: 0000902219-19-000015 Size: 37 KB 网页链接
$Nabriva Therapeutics(NBRV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-01 AccNo: 0001193125-19-025367 Size: 45 KB 网页链接
$Nabriva Therapeutics(NBRV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-01 AccNo: 0001193125-19-025367 Size: 45 KB 网页链接
$Nabriva Therapeutics(NBRV)$ 8-K - Current report Filed: 2019-01-14 AccNo: 0001104659-19-001838 Size: 45 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics(NBRV)$ 8-K - Current report Filed: 2019-01-04 AccNo: 0001104659-19-000791 Size: 47 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics(NBRV)$ 内部交易: 2018-12-24,Director,Rowland Charles A Jr ,买入,53000普通股, $1.31
$Nabriva Therapeutics(NBRV)$ 8-K - Current report Filed: 2018-12-21 AccNo: 0001104659-18-074266 Size: 58 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Re...
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ CT ORDER - Confidential treatment order Filed: 2018-11-29 AccNo: 9999999997-18-009158 Size: 93 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-06 AccNo: 0001104659-18-066303 Size: 8 MB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2018-11-06 AccNo: 0001104659-18-066192 Size: 190 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接